A Case of Neurodegeneration with Brain Iron Accumulation with novel Adaptor Protein-4 M1 subunit mutation
Objective: To present a patient with clinical and radiological features of neurodegeneration with brain iron accumulation (NBIA) due to a novel variant mutation in adaptor…Multi-modal MRI features and their relationship with clinical scales in Parkinson disease and Atypical Parkinsonian Syndromes
Objective: To compare MRI sings and volumetric measurements in Parkinson disease (PD), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA) and their relationship with…The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation
Objective: This study aims to identify differences of constipation symptoms in detail by using the constipation scoring system between PD patients and non-PD patients. Background:…Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease
Objective: In this report, real-world outcomes using Directional Deep Brain Stimulation (DBS) Systems with multiple independent current source control (MICC) for use in managing symptoms…Multiple system atrophy mimicked by mitochondrial disease.
Objective: Characterized a case with A3243G mutation in mtDNA tRNALeu, a variant of mitochondrial disease; MELAS, which presents with atypical parkinsonism as Multiple system atrophy.…Is there a role for safinamide in atypical parkinsonian syndromes?
Objective: To search for possible benefits of safinamide in atypical parkinsonism. Background: Safinamide is a selective reversible monoamine oxidase-B inhibitor with both dopaminergic and glutamatergic…Month 24 results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort
Objective: To describe the change in characteristics of Parkinson’s disease (PD) clinical trial participants over 24 months following trial participation in a remote, longitudinal observational…Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism
Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…Expanding the armamentarium of clinical use of apomorphine in movement disorders.
Objective: To demonstrate the use of subcutaneous(SC) apomorphine injections in suspected untreated dopamine responsive conditions. Background: Apomorphine is a dopamine agonist historically used in dopamine…Screening of REM Sleep Behavior Disorder and the relation with parkinsonism symptoms in the elderly in southern Brazil: a preliminary population-based study
Objective: To describe the preliminary screening profile for suspected REM sleep behavior disorders (RBD) and association with parkinsonian symptoms in the elderly in a population-based…
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 425
- Next Page »